Unknown

Dataset Information

0

Increasing reproducibility, robustness, and generalizability of biomarker selection from meta-analysis using Bayesian methodology.


ABSTRACT: A major limitation of gene expression biomarker studies is that they are not reproducible as they simply do not generalize to larger, real-world, heterogeneous populations. Frequentist multi-cohort gene expression meta-analysis has been frequently used as a solution to this problem to identify biomarkers that are truly differentially expressed. However, the frequentist meta-analysis framework has its limitations-it needs at least 4-5 datasets with hundreds of samples, is prone to confounding from outliers and relies on multiple-hypothesis corrected p-values. To address these shortcomings, we have created a Bayesian meta-analysis framework for the analysis of gene expression data. Using real-world data from three different diseases, we show that the Bayesian method is more robust to outliers, creates more informative estimates of between-study heterogeneity, reduces the number of false positive and false negative biomarkers and selects more generalizable biomarkers with less data. We have compared the Bayesian framework to a previously published frequentist framework and have developed a publicly available R package for use.

SUBMITTER: Kalesinskas L 

PROVIDER: S-EPMC9269905 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5989067 | biostudies-literature
| S-EPMC10789030 | biostudies-literature
| S-EPMC7721731 | biostudies-literature
| S-EPMC6591952 | biostudies-literature
2023-05-12 | GSE227710 | GEO
| S-EPMC8566820 | biostudies-literature
2018-10-31 | GSE89044 | GEO
| S-EPMC5543999 | biostudies-literature
| S-EPMC10105856 | biostudies-literature
| S-EPMC7820846 | biostudies-literature